IL13Rα2 chimeric antigen receptor T cells combined with checkpoint blockade to treat glioblastoma in human and canine models

被引：0
|
作者：
Yin, Y. [1 ]
Binder, Z. [1 ]
Thokala, R. [1 ]
O'Rourke, D. [1 ]
机构：
[1] Univ Penn, Neurosurg, Philadelphia, PA 19104 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
151 (PB-00
引用
收藏
页码：E57 / E57
页数：1
相关论文
共 50 条
  • [1] Combinatorial IL13Rα2 chimeric antigen receptor-T cells plus checkpoint blockade to treat solid tumors in murine and canine models
    Yin, Yibo
    Boesteanu, Alina
    Xu, Chong
    Posey, Avery
    Cook, Danielle
    Blouch, Kristin
    McGettigan-Croce, Bevin
    Mason, Nicola
    June, Carl H.
    Lin, Zhiguo
    Johnson, Laura A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [2] PHASE I STUDY OF CHIMERIC ANTIGEN RECEPTOR-ENGINEERED T CELLS TARGETING IL13Rα2 FOR THE TREATMENT OF GLIOBLASTOMA
    Brown, Christine
    Alizadeh, Darya
    Starr, Renate
    Weng, Lihong
    Wagner, Jamie
    Naranjo, Araceli
    Blanchard, Suzette
    Kilpatrick, Julie
    Simpson, Jennifer
    Ressler, Julie Ann
    Jensen, Michael
    Portnow, Jana
    D'Apuzzo, Massimo
    Barish, Michael
    Forman, Stephen
    Badie, Behnam
    NEURO-ONCOLOGY, 2016, 18 : 20 - 20
  • [3] Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
    Brown, Christine E.
    Badie, Behnam
    Barish, Michael E.
    Weng, Lihong
    Ostberg, Julie R.
    Chang, Wen-Chung
    Naranjo, Araceli
    Starr, Renate
    Wagner, Jamie
    Wright, Christine
    Zhai, Yubo
    Bading, James R.
    Ressler, Julie A.
    Portnow, Jana
    D'Apuzzo, Massimo
    Forman, Stephen J.
    Jensen, Michael C.
    CLINICAL CANCER RESEARCH, 2015, 21 (18) : 4062 - 4072
  • [4] Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma
    Pituch, Katarzyna C.
    Miska, Jason
    Krenciute, Giedre
    Panek, Wojciech K.
    Li, Gina
    Rodriguez-Cruz, Tania
    Wu, Meijing
    Han, Yu
    Lesniak, Maciej S.
    Gottschalk, Stephen
    Balyasnikova, Irina V.
    MOLECULAR THERAPY, 2018, 26 (04) : 986 - 995
  • [5] Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
    Brown, Christine E.
    Aguilar, Brenda
    Starr, Renate
    Yang, Xin
    Chang, Wen-Chung
    Weng, Lihong
    Chang, Brenda
    Sarkissian, Aniee
    Brito, Alfonso
    Sanchez, James F.
    Ostberg, Julie R.
    D'Apuzzo, Massimo
    Badie, Behnam
    Barish, Michael E.
    Forman, Stephen J.
    MOLECULAR THERAPY, 2018, 26 (01) : 31 - 44
  • [6] Phase I Study of Second Generation Chimeric Antigen Receptor-Engineered T Cells Targeting IL13Rα2 for the Treatment of Glioblastoma
    Brown, Christine E.
    Starr, Renate
    Weng, Lihong
    Alizadeh, Darya
    Wagner, Jamie R.
    Kilpatrick, Julie
    Harshbarger, Todd L.
    D'Apuzzo, Massimo
    Ressler, Julie A.
    Jensen, Michael C.
    Portnow, Jana
    Barish, Michael E.
    Forman, Stephen J.
    Badie, Behnam
    MOLECULAR THERAPY, 2016, 24 : S97 - S97
  • [7] Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study
    Kim, Kiwan
    Gwak, Ho-Shin
    Han, Nayoung
    Hong, Eun Kyung
    Choi, Beom K.
    Lee, Sangeun
    Choi, Soyoung
    Park, Ju-Hwang
    Seok, Ji-Hye
    Jeon, Yeongha
    Cho, Hyuntae
    Lee, Song-Jae
    Lee, Yura
    Nam, Ki Taek
    Song, Seong-Won
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [8] Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells
    Starr, Renate
    Aguilar, Brenda
    Gumber, Diana
    Maker, Madeleine
    Huard, Stephanie
    Wang, Dongrui
    Chang, Wen-Chung
    Brito, Alfonso
    Chiu, Vivian
    Ostberg, Julie R.
    Badie, Benham
    Forman, Stephen J.
    Alizadeh, Darya
    Wang, Leo D.
    Brown, Christine E.
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (01): : 66 - 79
  • [9] Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
    Schmidts, Andrea
    Srivastava, Ambike A.
    Ramapriyan, Rishab
    Bailey, Stefanie R.
    Bouffard, Amanda A.
    Cahill, Daniel P.
    Carter, Bob S.
    Curry, William T.
    Dunn, Gavin P.
    Frigault, Matthew J.
    Gerstner, Elizabeth R.
    Ghannam, Jack Y.
    Kann, Michael C.
    Larson, Rebecca C.
    Leick, Mark B.
    Nahed, Brian, V
    Richardson, Leland G.
    Scarfo, Irene
    Sun, Jing
    Wakimoto, Hiroaki
    Maus, Marcela, V
    Choi, Bryan D.
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [10] T CELLS EXPRESSING IL13Rα2-SPECIFIC CHIMERIC ANTIGEN RECEPTORS BASED ON IL13.E13K MUTEINS HAVE POTENT ANTI-GLIOMA ACTIVITY BUT ALSO RECOGNIZE IL13Rα1 CELLS
    Krebs, Simone
    Chow, Kevin
    Yi, Zhongzhen
    Brawley, Vita
    Ahmed, Nabil
    Gottschalk, Stephen
    NEURO-ONCOLOGY, 2013, 15 : 14 - 14
12345